Jim Simons Renovo Rx, Inc. Put Options Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.16 Million2.59% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$2.74 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.61 Million0.0% of portfolio
-
Bank Of The West975KShares$1.17 Million0.27% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$826,2920.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $10.9M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...